Zero knowledge and high interest in the use of long-acting injectable pre-exposure prophylaxis (PrEP) among adolescent men who have sex with men and transgender women in two capital cities in Brazil
Authors:
Open Access
- 12 September 2022
- journal article
- research article
- Published by Springer Nature in BMC Public Health
- Vol. 22 (1) , 1-10
Abstract
Background: Adolescent men who have sex with men (aMSM) and transgender women (aTGW) are affected disproportionately by human immunodeficiency virus (HIV) infection. Although new methods of pre-exposure prophylaxis (PrEP), such as long-acting injectable (LAI-PrEP), have been approved by the Food and Drug Administration, their acceptability among aMSM/aTGW is not well known.Methods: Forty-eight semi-structured interviews were conducted to assess the knowledge and interest in LAI-PrEP among aMSM/aTGW enrolled in a daily oral PrEP cohort from two capital cities of Brazil since 2019.Results: Previous knowledge of LAI-PrEP remains scarce, but the high interest regarding its use has been reported. Interest in the use of LAI-PrEP is associated with eliminating the burden of daily responsibility or the risk of missing the necessary medications, lowering the costs of this method, increasing confidentiality, and decreasing the frequency of visiting PrEP clinics. The reported barriers to uptake included fear of injection, doubts on its effectiveness, side effects, and greater dependence on a health provider.Conclusions: There is an urgent need to strengthen the preventive strategies against HIV infection among the youth, enhance their knowledge and those of healthcare providers, and offer safe and new options.Keywords
Funding Information
- Unitaid (2017-15-FIOTECPrEP, 2017-15-FIOTECPrEP, 2017-15-FIOTECPrEP, 2017-15-FIOTECPrEP, 2017-15-FIOTECPrEP, 2017-15-FIOTECPrEP, 2017-15-FIOTECPrEP, 2017-15-FIOTECPrEP, 2017-15-FIOTECPrEP)
This publication has 29 references indexed in Scilit:
- HIV Care Providers' Intentions to Prescribe and Actual Prescription of Pre-Exposure Prophylaxis to At-Risk Adolescents and AdultsAIDS Patient Care and STDs, 2017
- Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United StatesJAMA Pediatrics, 2017
- A scoping review of prevalence, incidence and risk factors for HIV infection amongst young people in BrazilBMC Infectious Diseases, 2017
- Thematic AnalysisInternational Journal of Qualitative Methods, 2017
- Preferences for Injectable PrEP Among Young U.S. Cisgender Men and Transgender Women and Men Who Have Sex with MenArchives of Sexual Behavior, 2017
- Preferences for Long-Acting Pre-exposure Prophylaxis (PrEP), Daily Oral PrEP, or Condoms for HIV Prevention Among U.S. Men Who Have Sex with MenAIDS and Behavior, 2016
- High Interest in a Long-Acting Injectable Formulation of Pre-Exposure Prophylaxis for HIV in Young Men Who Have Sex with Men in NYC: A P18 Cohort SubstudyPLOS ONE, 2014
- The importance of choice in the rollout of ARV‐based prevention to user groups in Kenya and South Africa: a qualitative studyJournal of the International AIDS Society, 2014
- Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort studyThe Lancet Infectious Diseases, 2014
- Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with MenNew England Journal of Medicine, 2010